NIH

The U.S. Supreme Court announced Monday that it would not hear a case that challenged the legality of federally funded human embryonic stem cell research. The case, Sherley v. Sebelius , was brought by two researchers of induced pluripotent stem cells, James Sherley, MD, PhD, and Theresa Deisher, PhD in 2009. They argued that guidelines concerning government funding of hESC, adopted by the Obama administration, were in violation of the 1996 Dickey-Wicker Amendment. The amendment forbids the Department of Health and Human Services ’€” including the National Institutes of Health ’€” from using appropriated funds to either create embryos for research purposes or conduct research in which...
Dear Research Advocate, The two-month reprieve from sequestration agreed to as part of the ’€œdeal’€ to avert the fiscal cliff is a partial victory for all who worked hard to save research, giving us much-needed additional time to make our case. We need be smart in using that time well, because the delay was paid for through a combination of new revenue and spending cuts that could further drain the pool of dollars used to fund research. The fact that many conservative members of Congress expressed outrage that the fiscal cliff deal didn’€™t include larger spending cuts underscores this point. The debt ceiling will need to be raised within the next two months, adding fuel to the fire. And...
Dear Research Advocate, Progress toward a deal to avert the fiscal cliff seems now to have been reversed, with talk today of reintroducing aspects of the Ryan budget ’€” more severe than sequestration. Holidays or not, this is no time to let up on our individual and collective advocacy for research. Reps. Fudge (D-OH) and Stivers (R-OH) are leading a bipartisan sign-on letter , urging Congress to take into account the critical importance of NIH in any deficit reduction plan. Take action and urge your representatives to sign on! For those of you in Ohio, if you would like to thank Reps. Fudge and Stivers for their efforts, you may obtain their contact information here . In addition to...
Dear Research Advocate, Are we heading over the fiscal cliff? You have probably seen the several public opinion polls saying most Americans now think it’€™s inevitable. (’€œMerry Cliftmas,’€ says Jon Stewart.) Our latest polling tracks with that of others ’€” and adds a timely insight. Just when one might least expect Americans to voluntarily increase what they owe to Uncle Sam, more than 50% say they would be willing to pay $1 more per week if they were sure the dollars would go to medical research. See this finding and more in a new poll we commissioned to take the pulse of Americans at this high-stakes time in our history. We have been asking about willingness to pay more in taxes for...
Dear Research Advocate, As our nation edges toward the fiscal cliff, the White House and House Republican leadership have been trading offers. The most recent Republican plan includes additional cuts to discretionary spending ’€” another $300 billion. These newly proposed discretionary cuts are significantly less than the across-the-board approach of sequestration, but suggest that ’€” absent a strong shift in the winds ’€” more discretionary spending cuts will be part of any final, compromise plan. It is highly unlikely that any final plan will be hammered out until next year; the president indicated as much in remarks he made Tuesday. The best guess is that policy makers will coalesce...
Dear Research Advocate, With a stellar team of advocates from across the research community, we have been blitzing Capitol Hill this week with our message that we need cures, not cuts. Research!America and our partners have participated in more than 60 meetings with Members of Congress, including key leadership and their staff. My thanks to the 140+ groups that signed on to our community letter to congressional leadership. Many partners have activated their grassroots to join the call Congress day, and there is still time to join the In-District Drop-In day (today) and a social media push on Friday. We also encourage you to keep up the drumbeat with emails and phone calls to Hill offices...
Pending Budget Cuts will Further Jeopardize Global Leadership in Research and Innovation WASHINGTON, DC ’€”October 25, 2012’€”Biomedical and health research and development (R&D) spending from all sources declined by more than $4 billion or 3% between FY10 and FY11 according to Research!America’€™s 2011 U.S. Investment in Health Research report. This represents the first drop in overall spending since Research!America began compiling the data in 2002. The decline follows an uptick in research funding attributed to the American Recovery and Reinvestment Act (ARRA), which allocated $10.4 billion to the National Institutes of Health (NIH) over two fiscal years (2009-2010). The overall...
Dear Research Advocate, Nine times. That’€™s how often the word ’€œresearch’€ was used in Monday’€™s third and final presidential debate. Clearly, both candidates recognize the importance of research and the role it plays in keeping our nation competitive. The election and decision-making around deficit reduction will put this rhetoric to the test. I was thankful for the opportunity to contribute to an article in Nature on the outlook for research and the candidates’€™ sometimes competing, sometimes intersecting visions for our nation. Many indicators point to the need for a ’€œgrand bargain’€ to avoid the fiscal cliff we have talked so much about. Rumors have it that informal talks are...
Dear Research Advocate, If we cut back our investments in science and research, we will lose out on the companies and innovation that come with it. That was the message President Obama delivered Tuesday night during the second presidential debate. Governor Romney mentioned the wisdom of keeping STEM graduates in the U.S. by ’€œstapling a green card’€ to their diplomas. In addition, Governor Romney responded to our Your Candidates ’€“ Your Health voter education initiative with a statement that stresses his commitment to ensuring government plays a role in supporting life sciences research and asserting that medical innovation must be a national priority. Please share both Governor Romney...
We extend our deepest condolences to Senator Arlen Specter’s family, friends and colleagues as they mourn the passing of a loved and respected statesman and a true champion of medical research. Specter’s leadership in generating critical support for medical and health research is a testament to his dedication to improving the health of all Americans and securing our position as a global leader in science and innovation. As a congressional leader, Specter played a pivotal role in the doubling of the National Institutes of Health (NIH) budget over five years and two Administrations and in 2009 assured that funding for the NIH and other health agencies were included in the American Recovery...

Pages

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America